16-30 of 86
Decision in Context: A Practical Framework for Sequencing Systemic and CNS Therapies in Brain Metastases
CME/CEDecision in Context: A Practical Framework for Sequencing Systemic and CNS Therapies in Brain Metastases
Barbara O'Brien, MD
HER2+ Breast Cancer With Brain Metastases: Rethinking First-Line Treatment in the ADC Era
MinuteCE®HER2+ Breast Cancer With Brain Metastases: Rethinking First-Line Treatment in the ADC Era
Barbara O'Brien, MD
Nadia Harbeck, MD, PhD
First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
MinuteCE®First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
Barbara O'Brien, MD
Nadia Harbeck, MD, PhD
Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC
MinuteCE®Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC
Benjamin Levy, MD
Melin Khandekar, MD, PhD
EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions
MinuteCE®EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions
Benjamin Levy, MD
Melin Khandekar, MD, PhD
Rethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
CME/CERethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
Mukul Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD, MSc, FRCPC
- advertisement
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
MinuteCE®Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
Christyn Edmundson, MD
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
Escalate With Intention: Stepwise, Target-Anchored Moves
MinuteCE®Escalate With Intention: Stepwise, Target-Anchored Moves
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
When to Begin FcRn: Initiation Criteria, Key Evidence
MinuteCE®When to Begin FcRn: Initiation Criteria, Key Evidence
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
- advertisement
Turning Flares Into Function: Flag Uncontrolled Disease
MinuteCE®Turning Flares Into Function: Flag Uncontrolled Disease
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
Early Clues, Lasting Impact: Detecting and Treating Alzheimer’s Disease in Its Earliest Stages
CME/CEEarly Clues, Lasting Impact: Detecting and Treating Alzheimer’s Disease in Its Earliest Stages
Anton P. Porsteinsson, MD
Vijay K. Ramanan, MD, PhD
Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline
CME/CEPrimary Care for the Brain: Prevention and Early Detection of Cognitive Decline
Emily D. Clark, DO
Tracey M. Piparo, PA-C, CAQ-PMHC, DFAAPA
Susan Scanland, MSN, CRNP, GNP-BC, CDP
Anthony J. Viera, MD, MPH
